Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Cultured over Different Spatial Scales.

Contractile motion is the simplest metric of cardiomyocyte health in vitro, but unbiased quantification is challenging. We describe a rapid automated method, requiring only standard video microscopy, to analyze the contractility of human-induced pluripotent stem cell-derived cardiomyocytes (iPS-CM). New algorithms for generating and filtering motion vectors combined with a newly developed isogenic iPSC line harboring genetically encoded calcium indicator, GCaMP6f, allow simultaneous user-independent measurement and analysis of the coupling between calcium flux and contractility. The relative performance of these algorithms, in terms of improving signal to noise, was tested. Applying these algorithms allowed analysis of contractility in iPS-CM cultured over multiple spatial scales from single cells to three-dimensional constructs. This open source software was validated with analysis of isoproterenol response in these cells, and can be applied in future studies comparing the drug responsiveness of iPS-CM cultured in different microenvironments in the context of tissue engineering.

[1]  C. January,et al.  Calcium Transients Closely Reflect Prolonged Action Potentials in iPSC Models of Inherited Cardiac Arrhythmia , 2014, Stem cell reports.

[2]  Nathaniel Huebsch,et al.  Three-dimensional filamentous human diseased cardiac tissue model. , 2014, Biomaterials.

[3]  Charless C. Fowlkes,et al.  Integrated platform for functional monitoring of biomimetic heart sheets derived from human pluripotent stem cells. , 2014, Biomaterials.

[4]  Ivan Rusyn,et al.  Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity. , 2013, Toxicology and applied pharmacology.

[5]  Jae Young Lee,et al.  Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development , 2013, Stem Cell Research & Therapy.

[6]  Natsuyo Aoyama,et al.  Phenotypic Screening with Human iPS Cell–Derived Cardiomyocytes , 2013, Journal of biomolecular screening.

[7]  Stefan R. Pulver,et al.  Ultra-sensitive fluorescent proteins for imaging neuronal activity , 2013, Nature.

[8]  M. Radisic,et al.  Biowire: a new platform for maturation of human pluripotent stem cell derived cardiomyocytes , 2013, Nature Methods.

[9]  Euan A Ashley,et al.  Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. , 2013, Cell stem cell.

[10]  Sean P. Palecek,et al.  Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions , 2012, Nature Protocols.

[11]  Atsushi Izawa,et al.  hESC-Derived Cardiomyocytes Electrically Couple and Suppress Arrhythmias in Injured Hearts , 2012, Nature.

[12]  Sean P. Palecek,et al.  Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[13]  G. Keller,et al.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. , 2012, Cell stem cell.

[14]  Wolfgang A. Linke,et al.  Terminal Differentiation, Advanced Organotypic Maturation, and Modeling of Hypertrophic Growth in Engineered Heart Tissue , 2011, Circulation research.

[15]  Samira Kiani,et al.  Genetic engineering of human ES and iPS cells using TALE nucleases , 2011, Nature Biotechnology.

[16]  Masato Saito,et al.  Non-invasive characterization of mouse embryonic stem cell derived cardiomyocytes based on the intensity variation in digital beating video. , 2010, The Analyst.

[17]  R. Passier,et al.  Inhibition of ROCK improves survival of human embryonic stem cell–derived cardiomyocytes after dissociation , 2010, Annals of the New York Academy of Sciences.

[18]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[19]  Adam J Engler,et al.  Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating , 2008, Journal of Cell Science.

[20]  Kim Cooper,et al.  Low access resistance perforated patch recordings using amphotericin B , 1991, Journal of Neuroscience Methods.

[21]  Berthold K. P. Horn,et al.  Determining Optical Flow , 1981, Other Conferences.

[22]  Takeshi Kunihiro,et al.  Noninvasive evaluation of contractile behavior of cardiomyocyte monolayers based on motion vector analysis. , 2012, Tissue engineering. Part C, Methods.

[23]  M. Laflamme,et al.  Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells. , 2011, Methods in molecular biology.

[24]  D. Seliktar,et al.  Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial. , 2007, Acta biomaterialia.

[25]  Stephan E Lehnart,et al.  Intracellular calcium release and cardiac disease. , 2005, Annual review of physiology.

[26]  K P Roos,et al.  Optical methods to evaluate the contractile function of unloaded isolated cardiac myocytes. , 1997, Journal of molecular and cellular cardiology.